INTEGRA LIFESCIENCES HOLDINGS CORP — Revenue by Fiscal Year
18 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/88457c7f-fdb4-4109-9738-1119f0292d59/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $1.6B | 2025-01-01 – 2025-12-31 | evidence 0000917520-26-000011 |
| FY 2024 | $1.6B | 2024-01-01 – 2024-12-31 | evidence 0000917520-25-000017 |
| FY 2023 | $1.5B | 2023-01-01 – 2023-12-31 | evidence 0000917520-24-000022 |
| FY 2022 | $1.6B | 2022-01-01 – 2022-12-31 | evidence 0000917520-23-000015 |
| FY 2021 | $1.5B | 2021-01-01 – 2021-12-31 | evidence 0000917520-22-000010 |
| FY 2020 | $1.4B | 2020-01-01 – 2020-12-31 | evidence 0000917520-21-000018 |
| FY 2019 | $1.5B | 2019-01-01 – 2019-12-31 | evidence 0000917520-20-000010 |
| FY 2018 | $1.5B | 2018-01-01 – 2018-12-31 | evidence 0000917520-19-000013 |
| FY 2017 | $1.2B | 2017-01-01 – 2017-12-31 | evidence 0000917520-19-000013 |
| FY 2016 | $992.1M | 2016-01-01 – 2016-12-31 | evidence 0000917520-19-000013 |
| FY 2015 | $882.7M | 2015-01-01 – 2015-12-31 | evidence 0000917520-16-000073 |
| FY 2014 | $796.7M | 2014-01-01 – 2014-12-31 | evidence 0000917520-16-000073 |
| FY 2013 | $696.8M | 2013-01-01 – 2013-12-31 | evidence 0000917520-16-000073 |
| FY 2012 | $830.9M | 2012-01-01 – 2012-12-31 | evidence 0000917520-13-000023 |
| FY 2011 | $780.1M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-081503 |
| FY 2010 | $732.1M | 2010-01-01 – 2010-12-31 | evidence 0000950123-11-017602 |
| FY 2009 | $682.5M | 2009-01-01 – 2009-12-31 | evidence 0000950123-11-017602 |
| FY 2008 | $654.6M | 2008-01-01 – 2008-12-31 | evidence 0000950123-11-017602 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
INTEGRA LIFESCIENCES HOLDINGS CORP — all facts · Net Income · Operating Income